These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6410727)

  • 1. Ioglunide: a new nonionic contrast medium for myelography and cisternography with reduced neurotoxicity.
    Gonsette RE; Liesenborghs L
    AJNR Am J Neuroradiol; 1983; 4(3):304-5. PubMed ID: 6410727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotoxicity of nonionic iodinated water-soluble contrast media in myelography: experimental study.
    Caillé JM; Gioux M; Arné P; Paty J
    AJNR Am J Neuroradiol; 1983; 4(6):1185-9. PubMed ID: 6419559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of arachnoiditis from experimental nonionic contrast media.
    Haughton VM; Ho KC
    Radiology; 1980 Aug; 136(2):395-7. PubMed ID: 6773100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iopamidol and metrizamide in cervical myelography: side effects, EEG, and CSF changes.
    Moschini L; Manara O; Bonaldi G; Cassinari V; Quilici N; Belloni G
    AJNR Am J Neuroradiol; 1983; 4(3):848-50. PubMed ID: 6410870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iohexol: a new nonionic contrast medium for myelography and cisternography with markedly reduced neurotoxicity.
    Gonsette RE; Liesenborghs L
    Invest Radiol; 1985; 20(1 Suppl):S32-6. PubMed ID: 3871751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metrizamide for myelography.
    de Villiers PD; Snyman PJ; van Rensburg M
    S Afr Med J; 1980 Mar; 57(13):476-7. PubMed ID: 7368003
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic focal seizure disorder as a manifestation of intracranial iophendylate.
    Pascuzzi RM; Roos KL; Scott JA
    Epilepsia; 1988; 29(3):294-6. PubMed ID: 3131136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arachnoid response to contrast media: a comparison of iophendylate and metrizamide in experimental animals.
    Haughton VM; Ho KC
    Radiology; 1982 Jun; 143(3):699-702. PubMed ID: 6805038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Weber-Christian's syndrome after pantopaque myelography].
    Charles P; Ronne K; Kraft M
    Ugeskr Laeger; 1975 Jul; 137(27):1540-1. PubMed ID: 1145865
    [No Abstract]   [Full Text] [Related]  

  • 10. Routine cervical myelography with overhead oblique projections and Pantopaque.
    Hatten HP
    Spine (Phila Pa 1976); 1982; 7(5):512-4. PubMed ID: 7178991
    [No Abstract]   [Full Text] [Related]  

  • 11. Reactions to iophendylate in relation to multiple sclerosis.
    Kaufmann P; Jeans WD
    Lancet; 1976 Nov; 2(7993):1000-1. PubMed ID: 62217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and morbidity of water soluble and oil-based myelography. Study compares both methods in 314 patients.
    Dombrowski ET; Rezaian SM; Northcutt C; Boyd W; Fundell L; Anderson C; Malesky E
    Orthop Rev; 1986 Jan; 15(1):24-9. PubMed ID: 3453436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iophendylate myelography induced thoracic arachnoiditis, arachnoid cyst and syrinx, four decades later.
    Gopalakrishnan CV; Mishra A; Thomas B
    Br J Neurosurg; 2010 Dec; 24(6):711-3. PubMed ID: 20979434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pantopaque pulmonary embolism following myelography.
    Aspelin P; Lester J
    Neuroradiology; 1977 Aug; 14(1):43-4. PubMed ID: 896043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraplegia as a complication of myelography with iophendylate.
    Rezaian SM; Mozafari TY
    Spine (Phila Pa 1976); 1980; 5(3):294-5. PubMed ID: 7394666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with iopamidol for myelography.
    Bockenheimer SA; Hillesheimer W
    AJNR Am J Neuroradiol; 1983; 4(3):314-6. PubMed ID: 6410731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thecal deformity after lumbar myelography with iophendylate (Myodil) and meglumine iothalamate (Conray 280).
    Johnson AJ; Burrows EH
    Br J Radiol; 1978 Mar; 51(603):196-202. PubMed ID: 630188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic urticaria and intermittent anaphylaxis. Reactions to lophendylate.
    Lieberman P; Siegle RL; Kaplan RJ; Hashimoto K
    JAMA; 1976 Sep; 236(13):1495-7. PubMed ID: 989117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bullous eruptions following iophendylate myelography.
    Nawalkha PL; Mathur NK
    J Indian Med Assoc; 1978 Jun; 70(12):282. PubMed ID: 152334
    [No Abstract]   [Full Text] [Related]  

  • 20. The choice of contrast agent for myelography in patients with nonpenetrating cervical spine trauma.
    Virapongse C; Wagner F; Sarwar M; Kier EL
    Radiology; 1983 May; 147(2):467-71. PubMed ID: 6836124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.